| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neurocrine Biosciences, Inc. (NBIX) has 17 insiders with recent SEC Form 4 filings, including 1 buy and 12 sells. NBIX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 140.4K | $23.04M | - | |
| Other | 52.8K | $8.66M | - | |
| Other | 46.8K | $7.67M | - | |
| Other | 39.6K | $6.50M | -36,937 | |
| Other | 36.8K | $6.05M | -22,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 22, 2019 | Bozigian Haig P. | Chief Development Officer | Sale+OE | 1,300 | $80.03 | $104,037.05 | -0.9% | |
| May 16, 2019 | Bozigian Haig P. | Chief Development Officer | Sale+OE | 66,667 | $80.13 | $5,341,893.38 | -10.5% | |
| May 13, 2019 | Grigoriadis Dimitri E. | Chief Research Officer | Sell | 1,657 | $75.44 | $125,007.23 | -1.4% | |
| May 13, 2019 | Bozigian Haig P. | Chief Development Officer | Sale+OE | 34,547 | $75.51 | $2,608,813.25 | -19.6% | |
| Mar 12, 2019 | Neurocrine Biosciences Inc | 10% Owner | Buy | 4,179,728 | $11.96 | $49,999,996.20 | New | |
| Feb 6, 2019 | Gano Kyle54 | Chief Business Development Off | Sell | 762 | $83.56 | $63,672.64 | -0.9% | |
| Feb 6, 2019 | Lloyd-Smith Malcolm49 | Chief Regulatory Officer | Sell | 920 | $83.58 | $76,893.78 | -4.6% | |
| Feb 6, 2019 | Lippoldt Darin60 | Chief Legal Officer | Sell | 791 | $83.52 | $66,063.37 | -3.9% | |
| Feb 6, 2019 | Grigoriadis Dimitri E. | Chief Research Officer | Sell | 531 | $84.03 | $44,621.58 | -0.4% | |
| Feb 6, 2019 | Gorman Kevin Charles55 | Chief Executive Officer | Sell | 4,096 | $84.23 | $344,985.60 | -1.0% |